NCT03420573Unknown不适用
Clinical Profile of Parkinson's Disease in Patients With Hepatitis C Infection
Kasr El Aini Hospital0 个研究点目标入组 300 人开始时间: 2018年3月最近更新:
适应症
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 300
- 主要终点
- Score of UPDRS
研究概览
简要总结
There is association between Hepatitis C and Parkinson's Disease as shown from previous studies. The clinical profile and natural history is not fully studied yet. We aim at studying the clinical characteristics of Parkinson's Disease in patients with hepatitis C infection.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 50 Years 至 80 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patient with history of Parkinson's Disease and Hepatitis C infection.
排除标准
- •Advanced liver cirrhosis.
- •Patients with hepatic failure.
- •Symptoms of Parkinson's plus syndrome.
结局指标
主要结局
Score of UPDRS
时间窗: 2 years
Severity of Motor and non motor symptoms
次要结局
未报告次要终点
研究者
Shaimaa El-Jaafary
Lecturer of Neurology
Kasr El Aini Hospital
相似试验
尚未招募
Unknown
Study to detect a link between duration of illness and Cognitive decline in patients with Parkinson’s disease.CTRI/2024/06/068650Shlok Bharadwaj
已完成
3 期
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's DiseaseParkinson's Disease (PD)NCT04380142AbbVie174
已完成
不适用
Study on Parkinson's disease and related disorders with dopamine transporter ligand [C-11]PE2IPatients of Parkinson's disease and related disordersJPRN-UMIN000014709Tokyo Metropolitan Institute of Gerontology200
已完成
2 期
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's DiseaseParkinson DiseaseNCT05781711Tanta University60
Unknown
2 期
Efficacy of Prazosin Versus Placebo Associated With Peg-Interferon Alpha 2b and Ribavirin in Chronic Hepatitis C With Genotype 1 or 4 and Severe FibrosisHepatitis C, ChronicFibrosisNCT00148837French National Agency for Research on AIDS and Viral Hepatitis112
